Clinical trial / 2015
Milled flaxseed reduced LDL cholesterol in patients with peripheral artery disease.
A double-blind trial randomized 110 patients with peripheral artery disease to foods containing 30 g of milled flaxseed (n=58) or 30 g of whole wheat (n=52) daily for 12 months. Flaxseed lowered circulating LDL cholesterol by 15% at 1 month (P=0.05), though differences between groups were not significant at 12 months (P=0.33). In participants also taking cholesterol-lowering drugs, flaxseed decreased LDL cholesterol by 8.5% at 12 months compared to a 3.0% increase with placebo (P=0.030).
- Study type
- Randomized controlled trial
- Who was studied
- 110 patients with peripheral artery disease
- What was measured
- Plasma total and LDL cholesterol
THE PAPER
Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease.
Edel AL, Rodriguez-Leyva D, Maddaford TG, Caligiuri SP, Austria JA, Weighell W, Guzman R, Aliani M, Pierce GN. J Nutr, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.